First Application of Genetically Modified, Live-cell, Pig Skin to a Human Wound

October 11, 2019

XenoTherapeutics, Inc., a regenerative medicine company specializing in xenotransplantation, received the Burke/Yannas Award for Best Bioengineering Paper today at the 51st conference of the American Burn Association for its research of Xeno-Skin™. Co-founders Paul Holzer, CEO and Jon Adkins, COO, accepted the award on the company’s behalf.

Contact Us

359 Newbury Street, 5th Floor Suite 526

Boston, MA 02115

617-939-7892

info@xenotherapeutics.org

Connect with us
SUBSCRIBE

Federal EIN Number: 81-1016095

© 2020 by XenoTherapeutics Foundation

  • Black Facebook Icon
  • Black Twitter Icon
  • LinkedIn